Macrophage ghost entrapped amphotericin B: a novel delivery strategy towards experimental visceral leishmaniasis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmaceutical Science
Link
http://link.springer.com/article/10.1007/s13346-018-00602-1/fulltext.html
Reference21 articles.
1. WHO fact sheet; Leishmaniasis 2017; URL http://www.who.int/mediacentre/factsheets/fs375/en/ accessed on 17.01.18.
2. Sundar S, More DK, Singh MK, Singh VP, Sharma S, Makharia A, et al. Failure of pentavalent antimony in visceral leishmaniasisin India: report from the center of the Indian epidemic. Clin Infect Dis. 2000;31:1104–7. https://doi.org/10.1086/318121 .
3. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007;5:873–82. https://doi.org/10.1038/nrmicro1748 .
4. Gradoni L, Soteriadou K, Louzir H, Dakkak A, Toz SO, Jaffe C, et al. Drug regimens for visceralleishmaniasis in Mediterranean countries. Tropical Med Int Health. 2008;13:1272–6. https://doi.org/10.1111/j.1365-3156.2008.02144.x .
5. Schwartzentruber DJ, Lawson DH, Richards JM, Conry RM, Miller DM, Treisman J, et al. gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. New Engl J Med. 2011;364:2119–27. https://doi.org/10.1056/NEJMoa1012863 .
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Macrophage‐Biomimetic Nanoplatform‐Based Therapy for Inflammation‐Associated Diseases;Small Methods;2023-11-30
2. Macrophage-mimetic nanomedicines for the treatment of diseases;Nanotechnology Principles in Drug Targeting and Diagnosis;2023
3. Nanoghosts for therapeutic applications;Advanced Nanoformulations;2023
4. Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment;Journal of Nanobiotechnology;2022-12-27
5. Limitations of current chemotherapy and future of nanoformulation-based AmB delivery for visceral leishmaniasis—An updated review;Frontiers in Bioengineering and Biotechnology;2022-12-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3